Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 375, pseudogene (RN7SL375P)

Target
RN7SL375P
Molecular classification
Other (Pseudogene; processed non-coding RNA pseudogene)
01

Overview

RN7SL375P is a processed pseudogene in humans, classified under non-coding RNAs. It is homologous to the functional 7SL RNA gene, which serves as a central scaffold of the signal recognition particle complex responsible for co-translational targeting of secretory proteins to the endoplasmic reticulum[7][8][9]. Unlike its parent gene, RN7SL375P does not code for functional RNA or protein and does not contribute to cellular processes such as protein secretion. Broadly, pseudogenes of the 7SL RNA family originate from genomic incorporation of reverse-transcribed RNA sequences rather than gene duplication, resulting in nonfunctional diversity across the genome[5]. Most 7SL pseudogenes, including RN7SL375P, are considered biologically inert, though some pseudogenes in other families may participate in regulatory RNA functions[4][6]. RN7SL375P is not recognized as a drug target, biomarker, or disease-associated locus in current literature or curated databases[1][2].

Other names
RN7SL375P
02

Mechanism of action

None (No mechanism of action exists for drugs targeting RN7SL375P.)

03

Biological functions

None (RN7SL375P itself is not known to encode a functional molecule; more generally, some pseudogenes may exert regulatory functions such as acting as competing endogenous RNAs, but specific functions for RN7SL375P have not been demonstrated[4][6].)
04

Disease associations

Other (No known direct disease involvement for RN7SL375P. Some pseudogenes in the 7SL RNA family may participate in regulatory effects related to cancer or inflammation, but RN7SL375P is not listed among those with clear roles[4][8].)
05

Safety considerations

None (There are no safety concerns or challenges associated with RN7SL375P as it is not a therapeutic target.)
06

Interacting drugs

None (No drugs are reported or known to interact with RN7SL375P.)
07

Biomarkers

None (RN7SL375P is not known as a biomarker for patient selection or efficacy monitoring.)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 375, pseudogene (RN7SL375P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 375, pseudogene (RN7SL375P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call